Glaxosmithkline Pharmaceuticals announces cessation of director
With effect from 31 December 2017
Glaxosmithkline Pharmaceuticals announced that Andrew Aristidou, Executive Director & CFO has ceased to be a Director & CFO of the Company from close of the business hours on 31 December, 2017.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content